


Ask a doctor about a prescription for ADVENTAN 1 mg/ml CUTANEOUS SOLUTION
PACKAGE LEAFLET: INFORMATION FOR THE USER
Adventan 1mg/ml cutaneous solution
Methylprednisolone aceponate
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
Contents of the pack:
Adventan solution is an anti-inflammatory medicine (a corticosteroid) for exclusive cutaneous use on the scalp.
Adventan solution inhibits inflammatory and allergic skin reactions, as well as those associated with an increase in the number of cells (hyperproliferation), leading to a reduction in redness and fluid accumulation (edema), and relieving itching, burning, or pain.
Adventan solution is indicated for the treatment of inflammatory scalp conditions, such as:
- Allergy to a substance that has come into contact with the scalp (allergic contact dermatitis), or
- Irritation due to substances of habitual use (irritant contact dermatitis)
Do not use Adventan 1 mg/ml solution
Warnings and precautions
Consult your doctor, pharmacist, or nurse before starting to use Adventan 1 mg/ml solution.
Use in children and adolescents
Adventan solution should not be used in children under 18 years of age, as there is no clinical experience available in this age group.
Use of Adventan with other medicines
Tell your doctor, pharmacist, or nurse that you are using, have recently used, or might use any other medicines.
No interactions with other medicines are known for Adventan solution.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.
To avoid any risk to the child, do not use Adventan solution if you are pregnant or breastfeeding, unless your doctor advises you to do so.
During breastfeeding, do not let the child come into contact with areas treated with Adventan solution.
Driving and using machines
Adventan solution does not affect the ability to drive or use machines.
Follow exactly the application instructions of this medicine indicated by your doctor or pharmacist. If in doubt, consult your doctor or pharmacist again.
CUTANEOUS USE ONLY ON THE SCALP.
The recommended dose is:
Adults and adolescents over 18 years:
Adventan solution is applied once a day to the affected areas of the scalp.
The solution should be applied in the form of drops with a gentle massage.
Your doctor will indicate the duration of treatment with Adventan solution, but it should not exceed 4 weeks.
Use in children
Children under 18 years of age should not use Adventan solution, as its safety has not been established in this age group.
If you use more Adventan 1 mg/ml solution than you should
Studies have shown that there is no expected risk after the application of a single overdose. Repeated overdoses may produce side effects (see section 4).
After accidental oral ingestion of the solution, effects due to the excipient isopropyl alcohol may be expected. These effects may manifest as symptoms of central nervous system depression after ingestion of only a few milliliters or gastrointestinal disturbances.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately, or go to a medical center, or call the Toxicology Information Service, Telephone 91 562 04 20, indicating the medicine and the amount ingested.
If you forget to use Adventan 1 mg/ml solution
Do not apply a double dose to make up for forgotten doses. If you have forgotten a dose, continue with your usual schedule as instructed by your doctor or as described in the leaflet.
If you stop using Adventan 1 mg/ml solution
If you stop using Adventan solution prematurely, the original symptoms of your skin problem may reappear. Please contact your doctor before stopping treatment with Adventan solution.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, Adventan solution can cause side effects, although not everybody gets them.
The assessment of side effects is based on the following frequencies:
Very common: affects more than 1 in 10 patients
Common: affects 1 to 10 in 100 patients
Uncommon: affects 1 to 10 in 1,000 patients
Rare: affects 1 to 10 in 10,000 patients
Very rare: affects less than 1 in 10,000 patients.
Frequency not known (cannot be estimated from the available data).
Skin and subcutaneous tissue disorders
Uncommon: seborrheic dermatitis of the scalp and hair loss
Frequency not known: skin atrophy, acne, telangiectasias, skin striae, perioral dermatitis, skin discoloration, and allergic skin reactions
General disorders and administration site conditions
Common: burning sensation at the application site
Uncommon: pruritus, pain, dryness, folliculitis, irritation, and eczema at the application site, and localized sensation of heat.
Frequency not known: vesicles and erythema at the application site, hirsutism
Eyes disorders:
Frequency not known: Blurred vision.
Side effects may occur not only in the treated area but also in completely different areas of the body. This occurs if the active substance (a corticosteroid) passes into the body through the skin. This, for example, can increase the pressure in the eye (glaucoma).
Reporting of side effects
If you experience any of the side effects, talk to your doctor or pharmacist, even if it is an effect not listed in this leaflet. You can also report side effects directly through the Spanish Pharmacovigilance System for Human Use Medicines, Website: www.notificaRAM.es.
By reporting side effects, you can help provide more information on the safety of this medicine.
Keep out of the sight and reach of children.
Do not store above 30°C.
Do not use Adventan solution after the expiry date stated on the pack after CAD. The expiry date is the last day of the month stated.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
Appearance of the product and pack contents
Adventan 1 mg/ml cutaneous solution is a clear, transparent liquid, presented in a multidose container with a dropper cap, with 50 ml and 20 ml.
Not all pack sizes may be marketed.
Marketing authorisation holder and manufacturer
Marketing authorisation holder:
LEO Pharma A/S
Industriparken 55
DK-2750 Ballerup
Denmark
Manufacturer:
Berlimed, S.A.
Polígono Industrial Santa Rosa
C/ Francisco Alonso, 7
28806 Alcalá de Henares (Madrid) - Spain
Date of last revision of this leaflet: October 2018
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
The average price of ADVENTAN 1 mg/ml CUTANEOUS SOLUTION in November, 2025 is around 8.71 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for ADVENTAN 1 mg/ml CUTANEOUS SOLUTION – subject to medical assessment and local rules.